Egypt

Egypt receives 1st shipment of Chinese vaccine tested in UAE

CAIRO (AP) — Egypt on Thursday received its first shipment of a Chinese coronavirus vaccine, which was tested in the United Arab Emirates and is said to be 86 percent effective.

The shipment by Chinese state-owned pharmaceutical giant Sinopharm landed at Cairo’s international airport from the UAE. Cairo and Abu Dhabi are close allies.

Egyptian Health Minister Hala Zayed and diplomats from China and the UAE were at the airport to greet the shipment.

Health ministry spokesman Khaled Megahed said in a statement that the government would first vaccinate health care workers, particularly those who deal with COVID-19 cases. He said they would receive two doses of the vaccine over 21 days.

Egypt, the Arab world’s most populous country, has seen an increase in confirmed coronavirus infections in recent weeks amid warnings by the government about a second wave of the pandemic. Egypt reported 445 newly confirmed coronavirus infections Thursday and 22 deaths from COVID-19, bringing the country’s overall tally to 120,147 cases, with 6,854 deaths.

The Sinopharm vaccine has been approved for emergency use in a few countries and the company is still conducting late-stage clinical trials in 10 nations.

Sinopharm’s vaccine relies on a killed virus, similar to how polio immunizations work.

Vaccines being developed by Western companies, like the shot made by Pfizer and its German partner BioNTech, target the coronavirus’ spike protein using RNA. The United Kingdom already has begun vaccinating people with the Pfizer shot.

Pfizer reports its shot as being 95 percent effective, while another RNA candidate from Moderna appears to be 94.5 percent effective. Results suggest a third vaccine from Oxford University and AstraZeneca is safe and about 70 percent effective, but questions remain about how well it may help protect those over 55.

By SAMY MAGDY

IMAGE: In this April 11, 2020, photo released by Xinhua News Agency, a staff member tests samples of a potential COVID-19 vaccine at a production plant of SinoPharm in Beijing (Zhang Yuwei/Xinhua via AP).

Related Articles

Back to top button